跳至主要内容
临床试验/NCT00152542
NCT00152542已完成3 期

Follow up at School-age of Children Participating in the Nitric Oxide Ventilatory Approach (NOVA) Study

University of Chicago1 个研究点 分布在 1 个国家目标入组 160 人开始时间: 2005年5月最近更新:
适应症
干预措施
相关药物

试验速览

阶段
3 期
状态
已完成
入组人数
160
试验地点
1
主要终点
Examine school-readiness at school-age in premature infants treated with iNO or placebo in the first week of life

研究概览

简要总结

Our previous data demonstrated that premature infants treated with inhaled nitric oxide at birth had improved neurodevelopmental outcomes at two years corrected age. We now wish to determine whether this benefit continues through school age.

详细描述

Two questionnaires (truncated versions of previously validated surveys), one for parent and another for teacher, for which written consent was previously obtained are being sent to parents. The teacher questionnaires will be delivered via parents. A clinic visit will accompany age appropriate neurodevelopmental examination, administration of the Functional Independence Measure for Children (WeeFIM) survey, and hearing and visual screening exams (if appropriate).

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Prevention
盲法
Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)

入排标准

年龄范围
4 Years 至 6 Years(Child)
性别
All
接受健康志愿者

入选标准

  • Children who participated in NOVA study and are of school age

排除标准

  • Children who participated in NOVA study but deceased post discharge

研究组 & 干预措施

Inhaled nitric oxide

Experimental

干预措施: Inhaled nitric oxide (Drug)

Placebo

Placebo Comparator

干预措施: Placebo (Drug)

结局指标

主要结局

Examine school-readiness at school-age in premature infants treated with iNO or placebo in the first week of life

时间窗: 4-7 years of age (between 2005-2006)

次要结局

  • Examine health status at early school-age(4-7 years of age (between 2005-2006))

研究者

申办方类型
Other
责任方
Sponsor

研究点 (1)

Loading locations...

相似试验